According to Soto, experts have determined —through a mathematical model— that a vaccine is useful against COVID-19 when its efficacy is over 60%.
"All vaccines have showed zero mortality with the original strain, a smaller number of hospitalizations, and a lower quantity of people in intensive care units," he indicated.
According to the expert, international studies have shown that this vaccine produces some type of clot in 0.5 people per one million inhabitants. However, COVID-19 produces more than 100,000 clot cases per one million inhabitants, he explained.
(END) SRE/RRC/MVB